Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.
D'Souza W, Alsaadi T, Montoya J, Carreño M, Di Bonaventura C, Mohanraj R, Yamamoto T, McMurray R, Shastri O, Villanueva V; PERMIT study group.
D'Souza W, et al.
Seizure. 2022 Aug;100:56-66. doi: 10.1016/j.seizure.2022.06.008. Epub 2022 Jun 15.
Seizure. 2022.
PMID: 35777333
Free article.
Safety and tolerability were assessed by evaluating adverse events (AEs) and discontinuation due to AEs. RESULTS: 156 patients had myoclonic seizures (59.0% female; mean age, 32.1 years; idiopathic generalised epilepsy, 89.1%; Juvenile Myoclonic Epilepsy, 63.1%; mon …
Safety and tolerability were assessed by evaluating adverse events (AEs) and discontinuation due to AEs. RESULTS: 156 patients had myoclo …